| GTO ID | GTC1824 |
| Trial ID | NCT03356808 |
| Disease | Lung Cancer |
| Therapy | CAR-T cell |
| Treatment | Lung cancer-specific T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | Antigen-specific T Cells Against Lung Cancer |
| Year | 2017 |
| Country | China |
| Company sponsor | Shenzhen Geno-Immune Medical Institute |
| Other ID(s) | GIMI-IRB-17023 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||
|
|||||||||